{"id":"https://openalex.org/W2607127088","doi":"https://doi.org/10.1111/ijcp.12944","title":"Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)","display_name":"Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)","alternate_titles":[],"publication_year":2017,"publication_date":"2017-04-16","ids":{"openalex":"https://openalex.org/W2607127088","doi":"https://doi.org/10.1111/ijcp.12944","mag":"2607127088","pmid":"https://pubmed.ncbi.nlm.nih.gov/28419650","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5485167"},"language":"en","primary_location":{"id":"doi:10.1111/ijcp.12944","doi":"https://doi.org/10.1111/ijcp.12944","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ijcp.12944","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ijcp.12944","source":{"id":"https://openalex.org/S22344484","display_name":"International Journal of Clinical Practice","issn_l":"1368-5031","issn":["1368-5031","1742-1241"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Practice","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2607127088"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ijcp.12944","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027594088","display_name":"Marcus John Drake","orcid":"https://orcid.org/0000-0002-6230-2552","observed_orcids":["https://orcid.org/0000-0002-6230-2552"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Marcus J. Drake","raw_affiliation_strings":["University of Bristol and Bristol Urological Institute, Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bristol and Bristol Urological Institute, Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047579820","display_name":"Scott MacDiarmid","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott MacDiarmid","raw_affiliation_strings":["Alliance Urology Specialists, Greensboro, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alliance Urology Specialists, Greensboro, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080266362","display_name":"Christopher Reginald Chapple","orcid":"https://orcid.org/0000-0002-2960-9931","observed_orcids":["https://orcid.org/0000-0002-2960-9931"]},"institutions":[{"id":"https://openalex.org/I2801732343","display_name":"Royal Hallamshire Hospital","ror":"https://ror.org/00514rc81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801732343","https://openalex.org/I4210102902"]},{"id":"https://openalex.org/I71422933","display_name":"Sheffield Hallam University","ror":"https://ror.org/019wt1929","country_code":"GB","type":"education","lineage":["https://openalex.org/I71422933"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christopher R. Chapple","raw_affiliation_strings":["Royal Hallamshire Hospital and Sheffield Hallam University, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Hallamshire Hospital and Sheffield Hallam University, Sheffield, UK","institution_ids":["https://openalex.org/I2801732343","https://openalex.org/I71422933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102920506","display_name":"Adil Esen","orcid":"https://orcid.org/0000-0002-8278-0586","observed_orcids":["https://orcid.org/0000-0002-8278-0586"]},"institutions":[{"id":"https://openalex.org/I193615760","display_name":"Dokuz Eyl\u00fcl University","ror":"https://ror.org/00dbd8b73","country_code":"TR","type":"education","lineage":["https://openalex.org/I193615760"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Adil Esen","raw_affiliation_strings":["Dokuz Eyl\u00fcl University School of Medicine; \u0130zmir Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dokuz Eyl\u00fcl University School of Medicine; \u0130zmir Turkey","institution_ids":["https://openalex.org/I193615760"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037776829","display_name":"Stavros Athanasiou","orcid":"https://orcid.org/0000-0003-0005-0369","observed_orcids":["https://orcid.org/0000-0003-0005-0369"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Stavros Athanasiou","raw_affiliation_strings":["University of Athens Medical School, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Athens Medical School, Athens, Greece","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101052704","display_name":"Javier Cambronero Santos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165557","display_name":"Hospital Universitario Infanta Leonor","ror":"https://ror.org/05nfzf209","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210165557"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Cambronero Santos","raw_affiliation_strings":["Infanta Leonor Hospital, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infanta Leonor Hospital, Madrid, Spain","institution_ids":["https://openalex.org/I4210165557"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034711178","display_name":"David Mitcheson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018163063","display_name":"St. Elizabeth's Medical Center","ror":"https://ror.org/00cr15z55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3018163063"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Mitcheson","raw_affiliation_strings":["St Elizabeth's Medical Center, Brighton, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St Elizabeth's Medical Center, Brighton, MA, USA","institution_ids":["https://openalex.org/I3018163063"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108589496","display_name":"Sender Herschorn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sender Herschorn","raw_affiliation_strings":["Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090982960","display_name":"Emad J. Siddiqui","orcid":"https://orcid.org/0000-0003-4855-8946","observed_orcids":["https://orcid.org/0000-0003-4855-8946"]},"institutions":[{"id":"https://openalex.org/I4210102929","display_name":"Astellas Pharma (United Kingdom)","ror":"https://ror.org/018788w33","country_code":"GB","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210102929"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Emad Siddiqui","raw_affiliation_strings":["Astellas Pharma Europe Ltd, Chertsey, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma Europe Ltd, Chertsey, Surrey, UK","institution_ids":["https://openalex.org/I4210102929"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049416260","display_name":"Moses Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102929","display_name":"Astellas Pharma (United Kingdom)","ror":"https://ror.org/018788w33","country_code":"GB","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210102929"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Moses Huang","raw_affiliation_strings":["Astellas Pharma Europe Ltd, Chertsey, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma Europe Ltd, Chertsey, Surrey, UK","institution_ids":["https://openalex.org/I4210102929"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076930803","display_name":"Matthias Stoelzel","orcid":"https://orcid.org/0000-0002-2058-7385","observed_orcids":["https://orcid.org/0000-0002-2058-7385"]},"institutions":[{"id":"https://openalex.org/I4210157866","display_name":"Astellas Pharma (Netherlands)","ror":"https://ror.org/04kyfd050","country_code":"NL","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210157866"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Matthias Stoelzel","raw_affiliation_strings":["Astellas Pharma Global Development, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astellas Pharma Global Development, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210157866"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5027594088"],"corresponding_institution_ids":["https://openalex.org/I36234482"],"apc_list":{"value":2350,"currency":"USD","value_usd":2350},"apc_paid":{"value":2350,"currency":"USD","value_usd":2350},"fwci":5.1365,"has_fulltext":true,"cited_by_count":26,"citation_normalized_percentile":{"value":0.95955273,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"71","issue":"5","first_page":"e12944","last_page":"e12944"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/overactive-bladder","display_name":"overactive bladder","score":0.972000002861023},{"id":"https://openalex.org/keywords/mirabegron","display_name":"mirabegron","score":0.8730000257492065},{"id":"https://openalex.org/keywords/solifenacin","display_name":"solifenacin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6320000290870667},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.75},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.5600000023841858},{"id":"https://openalex.org/keywords/tachycardia","display_name":"tachycardia","score":0.9409999847412109},{"id":"https://openalex.org/keywords/qt-interval-prolongation","display_name":"QT prolongation","score":0.9440000057220459},{"id":"https://openalex.org/keywords/anticholinergic-effects","display_name":"anticholinergic effects","score":0.7549999952316284},{"id":"https://openalex.org/keywords/refractory-incontinence","display_name":"refractory incontinence","score":0.7459999918937683},{"id":"https://openalex.org/keywords/alpha-1-adrenergic-agonists","display_name":"alpha-1 adrenergic agonists","score":0.6819999814033508},{"id":"https://openalex.org/keywords/antimuscarinic-agents","display_name":"antimuscarinic agents","score":0.7239999771118164},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.6370000243186951},{"id":"https://openalex.org/keywords/ecg-parameters","display_name":"ECG parameters","score":0.6840000152587891},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9740227460861206},{"id":"https://openalex.org/C2778164427","wikidata":"https://www.wikidata.org/wiki/Q3702534","display_name":"Mirabegron","level":4,"score":0.9643473625183105},{"id":"https://openalex.org/C2779502394","wikidata":"https://www.wikidata.org/wiki/Q59575279","display_name":"Solifenacin","level":4,"score":0.9485290050506592},{"id":"https://openalex.org/C2778941218","wikidata":"https://www.wikidata.org/wiki/Q331231","display_name":"Overactive bladder","level":3,"score":0.90529465675354},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.7382038235664368},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5901828408241272},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3283470869064331},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069464","descriptor_name":"Solifenacin Succinate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000069464","descriptor_name":"Solifenacin Succinate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000083","descriptor_name":"Acetanilides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000083","descriptor_name":"Acetanilides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016037","descriptor_name":"Single-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D053201","descriptor_name":"Urinary Bladder, Overactive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D058667","descriptor_name":"Adrenergic beta-3 Receptor Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D058667","descriptor_name":"Adrenergic beta-3 Receptor Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1111/ijcp.12944","doi":"https://doi.org/10.1111/ijcp.12944","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ijcp.12944","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ijcp.12944","source":{"id":"https://openalex.org/S22344484","display_name":"International Journal of Clinical Practice","issn_l":"1368-5031","issn":["1368-5031","1742-1241"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Practice","raw_type":"journal-article"},{"id":"pmid:28419650","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28419650","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical practice","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5485167","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5485167/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int J Clin Pract","raw_type":"Text"},{"id":"pmh:oai:research-information.bris.ac.uk:publications/01a7964a-0bd8-483f-b51b-2d0c989664f6","doi":null,"is_oa":true,"landing_page_url":"https://research-information.bris.ac.uk/en/publications/01a7964a-0bd8-483f-b51b-2d0c989664f6","pdf_url":null,"source":{"id":"https://openalex.org/S4306400895","display_name":"Bristol Research (University of Bristol)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I36234482","host_organization_name":"University of Bristol","host_organization_lineage":["https://openalex.org/I36234482"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drake, M J, MacDiarmid, S, Chapple, C R, Esen, A, Athanasiou, S, Cambronero Santos, J, Mitcheson, D, Herschorn, S, Siddiqui, E, Huang, M & Stoelzel, M 2017, 'Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)', International Journal of Clinical Practice, vol. 71, no. 5, e12944. https://doi.org/10.1111/ijcp.12944","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.whiterose.ac.uk:117093","doi":null,"is_oa":false,"landing_page_url":"http://eprints.whiterose.ac.uk/117093/1/Drake_et_al-2017-International_Journal_of_Clinical_Practice.pdf","pdf_url":"http://eprints.whiterose.ac.uk/117093/1/Drake_et_al-2017-International_Journal_of_Clinical_Practice.pdf","source":{"id":"https://openalex.org/S4306400854","display_name":"White Rose Research Online (University of Leeds, The University of Sheffield, University of York)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800616092","host_organization_name":"White Rose University Consortium","host_organization_lineage":["https://openalex.org/I2800616092"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire/01a7964a-0bd8-483f-b51b-2d0c989664f6","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1983/01a7964a-0bd8-483f-b51b-2d0c989664f6","pdf_url":"https://research-information.bris.ac.uk/files/118144662/Drake_et_al_2017_International_Journal_of_Clinical_Practice.pdf","source":{"id":"https://openalex.org/S7407055359","display_name":"Explore Bristol Research","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drake, M J, MacDiarmid, S, Chapple, C R, Esen, A, Athanasiou, S, Cambronero Santos, J, Mitcheson, D, Herschorn, S, Siddiqui, E, Huang, M & Stoelzel, M 2017, 'Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)', International Journal of Clinical Practice, vol. 71, no. 5, e12944. https://doi.org/10.1111/ijcp.12944","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dnet:ricscm______::098b8539ffb0c46b1519ed2f086fe148","doi":null,"is_oa":true,"landing_page_url":"https://repositoriosaludmadrid.es/handle/20.500.12530/39739","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:spiral.imperial.ac.uk:10044/1/104235","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10044/1/104235","pdf_url":null,"source":{"id":"https://openalex.org/S4306401396","display_name":"Spiral (Imperial College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I47508984","host_organization_name":"Imperial College London","host_organization_lineage":["https://openalex.org/I47508984"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"15","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/ijcp.12944","doi":"https://doi.org/10.1111/ijcp.12944","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ijcp.12944","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ijcp.12944","source":{"id":"https://openalex.org/S22344484","display_name":"International Journal of Clinical Practice","issn_l":"1368-5031","issn":["1368-5031","1742-1241"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Clinical Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320323599","display_name":"Astellas Pharma Europe","ror":"https://ror.org/018788w33"},{"id":"https://openalex.org/F4320332563","display_name":"Astellas Pharma Global Development","ror":"https://ror.org/05pw69n24"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2607127088.pdf","grobid_xml":"https://content.openalex.org/works/W2607127088.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W25873098","https://openalex.org/W154652144","https://openalex.org/W1522700698","https://openalex.org/W1575778540","https://openalex.org/W1583587392","https://openalex.org/W1632083014","https://openalex.org/W1833989893","https://openalex.org/W1948948667","https://openalex.org/W1967312126","https://openalex.org/W1972476372","https://openalex.org/W1972477468","https://openalex.org/W1986758727","https://openalex.org/W2001046671","https://openalex.org/W2032126389","https://openalex.org/W2033817897","https://openalex.org/W2037171825","https://openalex.org/W2056255004","https://openalex.org/W2063677232","https://openalex.org/W2072658132","https://openalex.org/W2085391324","https://openalex.org/W2128421946","https://openalex.org/W2129380410","https://openalex.org/W2131173377","https://openalex.org/W2131770336","https://openalex.org/W2144564072","https://openalex.org/W2145888765","https://openalex.org/W2160708362","https://openalex.org/W2293202443","https://openalex.org/W2331189781","https://openalex.org/W4285719527","https://openalex.org/W6683531534","https://openalex.org/W7043067862"],"related_works":["https://openalex.org/W2883546793","https://openalex.org/W2886808776","https://openalex.org/W2056255004","https://openalex.org/W2128421946","https://openalex.org/W2977423624","https://openalex.org/W4414374831","https://openalex.org/W4398137422","https://openalex.org/W2331189781","https://openalex.org/W2317400100","https://openalex.org/W4249500194"],"abstract_inverted_index":{"AIMS/OBJECTIVES:":[0],"-adrenoceptor":[1],"agonist":[2],"[mirabegron])":[3],"improved":[4],"efficacy":[5],"over":[6],"solifenacin":[7,38,64,123,130,167,182,216,226,255,265,295],"monotherapy":[8],"without":[9],"exacerbating":[10],"anticholinergic":[11],"side":[12],"effects":[13],"in":[14,86,148,211,234,278],"overactive":[15],"bladder":[16],"(OAB)":[17],"patients;":[18],"however,":[19],"a":[20,203],"potential":[21],"synergistic":[22,286],"effect":[23,287],"on":[24,288],"the":[25,200],"cardiovascular":[26],"(CV)":[27],"system":[28],"requires":[29],"investigation.":[30],"METHODS:":[31],"OAB":[32],"patients":[33],"remaining":[34],"incontinent":[35],"despite":[36],"daily":[37,50],"5":[39,53,65,124,168,266],"mg":[40,60,68,125,132,169,184,257,267],"during":[41],"4-week":[42],"single-blind":[43],"run-in,":[44],"were":[45,237],"randomised":[46],"1:1:1":[47],"to":[48,58,143,232],"double-blind":[49],"combination":[51,119,155,214,222,261],"(solifenacin":[52],"mg/mirabegron":[54],"25":[55],"mg,":[56],"increasing":[57],"50":[59],"after":[61],"week":[62],"4),":[63],"or":[66],"10":[67,131,183,256],"for":[69,244],"12":[70],"weeks.":[71],"CV":[72,289],"safety":[73,290],"assessments":[74],"included":[75],"frequency":[76,105,273],"of":[77,106,145,202,207,274],"CV-related":[78,275],"treatment-emergent":[79],"adverse":[80],"events":[81],"(TEAEs),":[82],"change":[83,140],"from":[84,141,230],"baseline":[85,142,231],"vital":[87,279],"signs":[88,280],"(systolic":[89],"blood":[90,94],"pressure":[91,95],"[SBP],":[92],"diastolic":[93],"[DBP],":[96],"pulse":[97,152],"rate)":[98],"and":[99,109,116,129,151,181,215,223,264,281,294],"electrocardiogram":[100],"(ECG)":[101],"parameters.":[102],"RESULTS:":[103],"The":[104,271],"hypertension,":[107],"tachycardia":[108],"ECG":[110,235,282],"QT":[111,245],"prolongation,":[112],"respectively,":[113],"was":[114,196,219,252],"low":[115],"comparable":[117,272],"across":[118,240],"(1.1%,":[120],"0.3%,":[121],"0.1%),":[122,128],"(0.7%,":[126],"0.1%,":[127],"groups":[133],"(0.8%,":[134],"0%,":[135],"0.1%).":[136],"Adjusted":[137],"mean":[138,204],"(SE)":[139],"end":[144],"treatment":[146,205,241],"(EoT)":[147],"SBP,":[149],"DBP,":[150],"rate":[153],"with":[154,199,221,225,254],"(0.07":[156],"mm":[157,161,171,175,186,190,209],"Hg":[158,162,172,176,187,191,210],"[0.38],":[159,173,188],"-0.35":[160],"[0.26],":[163,177,192],"0.47":[164],"bpm":[165,179,194],"[0.28]),":[166],"(-0.93":[170],"-0.45":[174],"0.43":[178],"[0.28])":[180,195],"(-1.28":[185],"-0.48":[189],"0.27":[193],"generally":[197,238],"comparable,":[198],"exception":[201],"difference":[206],"~1":[208],"SBP":[212,218],"between":[213],"monotherapy;":[217],"unchanged":[220],"decreased":[224],"monotherapy.":[227],"Mean":[228],"changes":[229,277],"EoT":[233],"parameters":[236,283],"similar":[239],"groups,":[242],"except":[243],"interval":[246],"corrected":[247],"using":[248],"Fridericia's":[249],"formula,":[250],"which":[251],"higher":[253],"(3.30":[258],"mseconds)":[259,263],"vs.":[260],"(0.49":[262],"(0.77":[268],"mseconds).":[269],"CONCLUSION:":[270],"TEAEs,":[276],"indicates":[284],"no":[285],"outcomes":[291],"when":[292],"mirabegron":[293],"are":[296],"combined.":[297]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2607127088","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-04-28T00:00:00"}
